⌕
Takeda Pharmaceutical · TAK · NYSE
Tenet 32 · Weak
Compare
$21.43+1.47%At closeTenet 32 · Weak
$21.43+0.31 (+1.47%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD

Takeda Pharmaceutical (TAK) Stock

Takeda Pharmaceutical (TAK) closed at $21.43 on Nov 13, 2026; its Tenet Score is 32 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

3 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$21.43
Nov 13, 2026
Market cap
$36.9Bunverified basis
share basis not confirmed
Dividend yield
2.94%
past year's regular dividends ÷ price
52-week range
13.91 – 21.73
low → high
Tenet Score
32/100
Weak · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Takeda Pharmaceutical Co scores 32/100. Weak. Financial health is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 32 is built from 3 of 4 pillars, from 65% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=409
32/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
—
Quality
43
Health
9
Growth
44

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Value omitted — no data yet.
Value—QualityDHealthFGrowthDMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
loss
P/B
2.1×
price to book value
P/S
2.6×
price to sales
ROE
−3%
return on equity
Operating margin
0.1%
before interest and tax
Net margin
−3.4%
of revenue kept
Current ratio
1.09
current assets to liabilities
Net debt / EBITDA
6.9×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).

The whole report, at a glance · every card is a live peek, click any to open the section

About Takeda Pharmaceutical Co

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rar…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 17 US ETFs · top wrappers by weightSee all ETFs holding TAK →

What sector and industry is Takeda Pharmaceutical in?

Takeda Pharmaceutical is in the Healthcare sector and the Drugs industry.

What is Takeda Pharmaceutical's Tenet Score?

Takeda Pharmaceutical's Tenet Score is 32 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.